1. Old epilepsy drug repurposed as a low-cost metabolic vaccine booster increases T-cell responses 10-fold in a human trial Summary: A multiomic screen matched T-cell memory transcriptional signatures against more than...
1. JN.1 booster shows surprising reach: cross-hits BA.3.2.2 and keeps a monoclonal option alive In this short immunogenicity study, 25 adults receiving a monovalent JN.1 mRNA vaccine provided serum before and about 12...
A one-size-fits-all approach for scheduling COVID-19 booster shots may not be the most effective, according to a new study by researchers at the Yale School of Public Health (YSPH) and University of North Carolina at...
If the effects don’t fade too rapidly, new data suggests regular COVID-19 vaccinations could strengthen our immune systems against future variants and even related viruses. This is on top of the proven protection...
COVID-19 mRNA booster vaccines offered protection against severe COVID-19 caused by the Omicron variant for at least 6 months, and three doses of China’s inactivated vaccines were more protective than two doses...
A top Pfizer executive says the company is hopeful that booster shots will provide sufficient protection against the Omicron variant — but has already envisioned a timeline for the development of a new vaccine if that’s...
Jonas Salk created a vaccine against polio that has been used since 1955; Albert Sabin created another version that has been on the market since 1961. Together, these two vaccines have nearly eliminated polio from the...
Imagine a world where tetanus and diphtheria (Td) booster vaccines are administered every 30 years instead of every 10. That’s what a new study published in Clinical Infectious Diseases suggests could be possible. The...
A new study has shown that adults don’t need to be given a tetanus booster shot every 10 years. This would save millions of dollars in health care costs if the adult vaccination schedule was revised. Tetanus, or...
Scientists have discovered a new way to manipulate how cells function, a finding that might help advance an experimental approach to improving public health: DNA vaccines, which could be more efficient, less expensive...